Skip to main content

Table 3 MRSE of Treatment Groups (D)

From: Safety and effectiveness of the SUPRACOR presbyopic LASIK algorithm on hyperopic patients

MRSE

Group A

Dominant

(Supracor)

Group A

Non Dominant

(Supracor)

Group B

Dominant

(LASIK)

Group B

Non-Dominant

(Supracor)

Group C

Dominant

(No treatment)

Group C

Non-Dominant

(Supracor)

Pre-Op

1.81 ± 0.32

1.76 ± 0.38

1.63 ± 0.46

1.81 ± 0.72

0.76 ± 0.38

0.78 ± 0.48

1 month

−0.39 ± 0.55

−0.51 ± 0.61

−0.16 ± 0.37

−1.06 ± 0.78

0.68 ± 0.44

−0.78 ± 0.59

3 months

−0.32 ± 0.40

−0.53 ± 0.42

0.10 ± 0.31

−0.76 ± 0.63

0.66 ± 0.39

−0.51 ± 0.60

6 months

−0.47 ± 0.24

−0.59 ± 0.64

0.01 ± 0.21

−0.55 ± 0.63

0.60 ± 0.46

−0.45 ± 0.38